Genetic risk of age-related maculopathy: Population-based familial aggregation study

Archives of Ophthalmology

Volumn 116, Issue 12, 1998, Pages 1646-1651

  Klaver, Caroline C W ^a   Wolfs, Roger C W ^a   Assink, Jacqueline J M ^a,b   Van Duijn, Cornelia M ^a   Hofman, Albert ^a   De Jong, Paulus T V M ^a,b,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RELATIVE; RETINA MACULA AGE RELATED DEGENERATION;

EID: 0032438352     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.12.1646     Document Type: Article

References (30)

1. Klaver CCW, Wolfs RCW, Vingerling JR, Hofman A, de Jong PTVM. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116:653-658.
2. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102:205-210.
3. Freund KB, Yannuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol. 1993;115:786-791.
4. Klaver CCW, Assink JJM, Vingerling JR, Hofman A, de Jong PTVM. Smoking is also related with age-related macular degeneration in persons aged 85 years and older: the Rotterdam Study [letter]. Arch Ophthalmol. 1997;115:945.
5. Vingerling JR, Hofman A, Grobbee DE, de Jong PTVM. Age-related macular degeneration and smoking: the Rotterdam Study. Arch Ophthalmol. 1996;114:1193-1196.
6. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA. 1996; 276:1141-1146.
7. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PTVM. Age-related macular degeneration is associated with atherosclerosis: the Rotterdam Study. Am J Epidemiol. 1995;142:404-409.
8. Vingerling JR, Dielemans I, Witteman JC, Hofman A, Grobbee DE, de Jong PTVM. Macular degeneration and early menopause: a case-control study. BMJ. 1995; 310:1570-1571.
9. Anonymous. Risk factors for neovascular age-related macular degeneration: the Eye Disease Case Control Study Group. Arch Ophthalmol. 1992;110:1701-1708.
10. Klein ML, Mauldin WM, Stoumbos VD. Heredity and age-related macular degeneration: observations in monozygotic twins. Arch Ophthalmol. 1994;112:932-937.
11. Meyers SM, Greene T, Gutman FA. A twin study of age-related macular degeneration. Am J Ophthalmol. 1995;120:757-766.
12. Heiba IM, Elston RC, Klein BEK, Klein R. Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol. 1994;11:51-67.
13. Allikmets R, Shroyer NF, Singh N, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science. 1997;277:1805-1807.
14. Silvestri G, Johnston PB, Hughes AE. Is genetic predisposition an important risk factor for age-related macular degeneration? Eye. 1995;8:564-568.
15. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol. 1997;123:199-206.
16. Hofman A, Grobbee DE, de Jong PWM, van den Ouweland FA. Determinants and disabilities in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7:403-422.
17. The International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995;39:367-374.
18. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. Ophthalmology. 1995;102:1450-1460.
19. Klein R, Klein BEK, Jensen S, Meuer SM. The five-year incidence and progression of age-related maculopathy. Ophthalmology. 1997;104:7-21.
20. Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population of 60-year-old men and women. J Chronic Dis. 1981;34:261-269.
21. Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis: the Rotterdam Study. Arterioscler Thromb. 1994;14:1885-1891.
22. Chase GA, Folstein MF, Breitner JCS, Beaty TH, Self SG. The use of lifetables and survival analysis in testing genetic hypotheses, with an application to Alzheimer's disease. Am J Epidemiol. 1983;117:590-597.
23. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974;99:325-332.
24. Mares-Perlman JA, Klein R, Klein BEK, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol. 1996;114:991-997.
25. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration: Eye Disease Case Control Study Group. JAMA. 1994;272:1413-1420.
26. Klein R, Klein BEK, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1993;100:406-414.
27. Khoury MJ, Beaty TH, Liang KY. Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol. 1988;127:674-683.
28. Piguet B, Wells JA, Palmvang IB, Wormald R, Chisholm IH, Bird AC. Age-related Bruch's membrane change: a clinical study of the relative role of heredity and environment. Br J Ophthalmol. 1993;77:400-403.
29. Deutman AF, Jansen LMAA. Dominantly inherited drusen of Bruch's membrane. Br J Ophthalmol. 1970;54:373-382.
30. De La Paz MA, Pericak-Vance MA, Haines JL, Seddon JM. Phenotypic heterogeneity in families with age-related macular degeneration. Am J Ophthalmol. 1997; 124:331-343.